title: Clinical relevance of inherited thrombophilia in implantation failure: who needs to be screened?
authors.forename: Elvira
authors.initials: E
authors.lastname: Grandone
authors.forename: Donatella
authors.initials: D
authors.lastname: Colaizzo
authors.forename: Arianna
authors.initials: A
authors.lastname: Lo Bue
authors.forename: Filomena
authors.initials: F
authors.lastname: Cappucci
authors.forename: Ettore
authors.initials: E
authors.lastname: Cittadini
authors.forename: Maurizio
authors.initials: M
authors.lastname: Margaglione
mesh_terms: D000026:Abortion, Habitual / Q000097:blood / Q000209:etiology* / Q000517:prevention & control; D000328:Adult; D010064:Embryo Implantation / Q000502:physiology*; D004624:Embryo Transfer; D005165:Factor V / Q000235:genetics; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006801:Humans; D008403:Mass Screening; D018579:Patient Selection; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000517:prevention & control*; D011516:Prothrombin / Q000235:genetics; D019851:Thrombophilia / Q000150:complications / Q000175:diagnosis* / Q000235:genetics; D013927:Thrombosis / Q000517:prevention & control*
chemical_list: D005343:Fibrinolytic Agents; C095381:factor V Leiden; D005165:Factor V; D011516:Prothrombin